Metal-salen complex compound responsive drug and intra-corporeal behavior control system for metal-salen complex compound
US9468621B2 · kind B2 · utility
0Cited by
2References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 19, 2012 |
| Grant date | Oct 18, 2016 |
| Priority date | — |
| Expiry date | Sep 19, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P39/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A metal-salen complex compound responsive drug, which has an antidotal property capable of neutralizing cytotoxicity of a metal-salen complex compound, and an intra-corporeal behavior control system for the metal-salen complex compound are provided. This metal-salen complex compound responsive drug contains an effective amount of a metal chelating agent to suppress side effects by the metal-salen complex compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.